Latest Breaking News On - Friedrich alexander university erlangen n - Page 1 : comparemela.com

人類學 – 開欄文 - 時事論壇 - udn城市

人類學 – 開欄文 - 時事論壇 - udn城市

Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma

Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn (UKB) and Clinician Scientist of the BMBF-funded ACCENT program and PD Dr. Markus Eckstein, senior physician at the Institute of Pathology at the Uniklinikum Erlangen of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), an interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab vedotin.

人類學 – 開欄文 - 時事論壇 - udn城市

'A wonder cell that's already widespread in our bodies could hold the key to treating arthritis' - Miriam Stoppard

A groundbreaking new study has helped to advance our understanding of the complex interplay between the cells which usually protect and lubricate our joints but which can turn nasty and inflammatory